How Worried Should Investors Be About Gossamer Bio Inc (GOSS)

Gossamer Bio Inc (NASDAQ:GOSS) does about 1.60M shares in volume on a normal day but saw 1092808 shares change hands in Friday’s trading. The company now has a market cap of 124.06M USD. Its current market price is $0.55, marking a decrease of -8.60% compared to the previous close of $0.60. The 52 week high reached by this stock is $1.88 whilst the lowest price level in 52 weeks is $0.45.

Gossamer Bio Inc (GOSS) has a 20-day trading average at $0.6407 and the current price is -70.83% off the 52-week high compared with 21.19% distance from its 52-week low. The 50-day simple moving average of the closing price is $0.7764 and its 200-day simple moving average is $0.8833. If we look at the stock’s price movements over the week, volatility stands at 9.75%, which decreases to 7.25% over 1 month. It is also key to look at other market indicators of price movement for the stock, where we see that the relative strength index (RSI) is at 29.83 to suggest the stock is oversold.

The consensus objective for the share price is $6.09, suggesting that the stock has a potential upside of 90.97% over the period.

The company shares received a number of brokerage firm price updates over the past month, with the latest being on April 05, 2024 when Wedbush resumed the stock to “Outperform” and issued a price target of $4. UBS downgraded the stock to “Neutral” from Buy on July 27, 2023 at a price target of $8-$1.25.

Gossamer Bio Inc (GOSS) stock is down -7.05% over the week and -27.40% over the past month. Its price is -39.90% year-to-date and -54.68% over the past year.

To reach the target analysts have set, the stock logically needs to grow 90.97 percent from here.

The company has a return on investment of -77.20% and return on equity of -480.50%. The beta has a value of 1.86. Price to book ratio is 4.64.